Long Term Follow-up (LTFU) Model: Efficient solutions for long term study success

Rare Disease Trials in India: A Patient’s Journey Through Science, Barriers, and Hope

Dunja Mihajlovic, M.D, PhD

Dunja Mihajlovic, M.D, PhD is a board-certified anesthesiologist and intensive care specialist with more than 15 years of clinical and research experience.

Ryan Zantua, MD

Ryan Zantua, MD joined Fortrea in 2020 where currently he works as a medical lead for several respiratory studies.

Scott Dove, PhD

Scott Dove, PhD joined Fortrea in January 2026 as President, Clinical Pharmacology Services, collaborating with biopharmaceutical and biotechnology companies to optimize early clinical development through excellence in study design and execution.

Centralized Delivery: Global hubs. Local impact. Accelerated outcomes.

Hybrid Delivery: Where agility meets innovation

Unitized Clinical FSP Delivery: Tailored. Flexible. Efficient.

Overcoming Recruitment and Retention Challenges in Prader-Willi Syndrome Drug Development